Trial intelligence / Profile preview

Zolpidem with adaptive servo-ventilation versus placebo in central sleep apnea with chronic heart failure

2015-003119-39Phase 4Active

Sponsor
CHU Grenoble Alpes
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in chronic heart failure (CHF), central sleep apnea (CSA) and sleep apnea comparing Zolpidem + adaptive servo-ventilation with Placebo + adaptive servo-ventilation (2 arms). Started Feb 2016; status: active.

02

Drugs

zolpidem
03

Conditions

chronic heart failure (CHF)central sleep apnea (CSA)sleep apnea

Beyond the preview

Go deeper on 2015-003119-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003119-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call